3-Methyl-8-Quinolinesulphonyl Chloride CAS 74863-82-4 Argatroban Intermediate Factory 98.0%
Manufacturer Supply Argatroban Related Intermediates:
Ethyl (2R,4R)-4-Methyl-2-Piperidinecarboxylate CAS 74892-82-3
N-Nitro-1,2,3,4-tetradehydro Argatroban Ethyl Ester CAS 74874-09-2
3-Methyl-8-Quinolinesulphonyl Chloride CAS 74863-82-4
Argatroban Monohydrate CAS 141396-28-3
Argatroban Anhydrous CAS 74863-84-6
Chemical Name | 3-Methyl-8-Quinolinesulphonyl Chloride |
Mashoko anoreva zvakafanana | 3-Methylquinoline-8-Sulfonyl Chloride |
Nhamba yeCAS | 74863-82-4 |
Nhamba yeCAT | RF-PI269 |
Stock Status | MuStock, Kugadzirwa Kunokwira Kusvika Matani |
Molecular Formula | C10H8ClNO2S |
Molecular Weight | 241.69 |
Density | 1.4±0.1 g/cm3 |
Refractive Index | 1.63 |
Solubility | Soluble muChloroform |
Shipping Condition | Yakatumirwa Pasi peAmbient Temperature |
Brand | Ruifu Chemical |
Item | Zvinotsanangurwa |
Chitarisiko | White Crystalline Powder |
Kuchena / Analysis Method | >98.0% (HPLC) |
Melting Point | 162.0~163.0℃ |
Kurasika paKuomesa | <0.50% |
3-Methylquinoline-8-Sulfonic Acid | <1.00% |
Zvose Zvisina Kuchena | <2.00% |
Infrared Spectrum | Inopindirana neChimiro |
NMR | Inopindirana neChimiro |
Test Standard | Enterprise Standard |
Usage | Pakati peArgatroban (CAS 74863-84-6) |
Package: Bhodhoro, Aluminium foil bag, 25kg/Cardboard Drum, kana zvinoenderana nezvinodiwa nemutengi.
Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza & mwando
Shanghai Ruifu Chemical Co., Ltd ndiyo inotungamira mugadziri uye mutengesi we3-Methyl-8-Quinolinesulphonyl Chloride (CAS: 74863-82-4) ine mhando yepamusoro, inoshandiswa zvakanyanya muorganic synthesis, synthesis yemishonga yepakati uye Active Pharmaceutical Ingredient. (API) synthesis.Itiri pakati kazhinji mukugadzirwa kweArgatroban (CAS: 74863-84-6) kana Argatroban Monohydrate (CAS 141396-28-3).
Argatroban (CAS: 74863-84-6) is anticoagulant iyo idiki molecule yakananga thrombin inhibitor.Muna 2000, argatroban yakabvumirwa neFood and Drug Administration (FDA) yeprophylaxis kana kurapwa kwethrombosis kune varwere vane heparin-induced thrombocytopenia (HIT).Muna 2002, yakatenderwa kushandiswa panguva yepercutaneous coronary interventions kune varwere vane HIT kana vari panjodzi yekuigadzira.Muna 2012, yakatenderwa neMHRA kuUK kuti iite anticoagulation muvarwere vane heparin-induced thrombocytopenia Type II (HIT) vanoda parenteral antithrombotic therapy.